nach oben

Erschienen in:

Open Access 06.08.2020 | SARS-CoV-2 | Letter

A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial

verfasst von: Miguel Rodríguez-Rubio, Juan Carlos Figueira, Darío Acuña-Castroviejo, Alberto M. Borobia, Germaine Escames, Pedro de la Oliva

Titel: A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial
verfasst von: Miguel Rodríguez-Rubio
Juan Carlos Figueira
Darío Acuña-Castroviejo
Alberto M. Borobia
Germaine Escames
Pedro de la Oliva
Publikationsdatum: 06.08.2020
Verlag: BioMed Central
Schlagwort: SARS-CoV-2
Erschienen in: Trials / Ausgabe 1/2020
Elektronische ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-020-04632-4